ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
AN2 Therapeutics Inc

AN2 Therapeutics Inc (ANTX)

1.42
0.03
(2.16%)
Closed 05 January 8:00AM
1.40
-0.02
(-1.41%)
After Hours: 10:57AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -12.48M-16.04M-16.6M-18.18M-18.82M-18.3M-15.88M-14.01M
Pre Tax Income -11.84M-15.32M-15.8M-16.71M-16.9M-16.62M-14.44M-12.75M
Net Income -11.84M-15.32M-15.8M-16.71M-16.9M-16.62M-14.44M-12.75M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -12.47M-15.32M-15.8M-16.71M-16.9M-16.62M-14.44M-12.75M
EBITDA -12.48M-16.04M-16.6M-18.18M-18.82M-18.3M-15.88M-14.01M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -21.57M-42.26M-69.64M
Pre Tax Income -21.54M-40.96M-64.73M
Net Income -28.06M-42.78M-64.73M
Preferred Dividends -6.52M-1.82M0
Basic Earnings Per Share (EPS) -0.005-2.205-2.177
EBIT -21.61M-42.31M-64.73M
EBITDA -21.57M-42.26M-69.64M

Your Recent History

Delayed Upgrade Clock